Andrew Cooper
Stock Analyst at Raymond James
(0.53)
# 4,118
Out of 4,547 analysts
204
Total ratings
40.2%
Success rate
-3%
Average return
Main Sectors:
Stocks Rated by Andrew Cooper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCA HCA Healthcare | Reiterated: Hold | n/a | $373.75 | - | 1 | Jul 15, 2026 | |
| HAE Haemonetics | Reiterated: Buy | n/a | $77.26 | - | 13 | Jul 13, 2026 | |
| ITGR Integer Holdings | Reiterated: Buy | $95 → $101 | $96.93 | +4.20% | 6 | Feb 23, 2026 | |
| GH Guardant Health | Reiterated: Buy | $61 → $129 | $150.64 | -14.37% | 11 | Feb 23, 2026 | |
| MYGN Myriad Genetics | Maintained: Buy | $8 | $5.71 | +40.23% | 9 | Jan 13, 2026 | |
| AZTA Azenta | Reiterated: Buy | $35 → $45 | $26.77 | +68.10% | 4 | Nov 25, 2025 | |
| AVTR Avantor | Downgraded: Hold | n/a | $10.99 | - | 15 | Nov 4, 2025 | |
| RVTY Revvity | Reiterated: Buy | $115 | $110.51 | +4.06% | 8 | Oct 28, 2025 | |
| QDEL QuidelOrtho | Maintained: Buy | $60 → $55 | $16.41 | +235.16% | 28 | Aug 6, 2025 | |
| FLGT Fulgent Genetics | Reiterated: Buy | $25 | $19.54 | +27.94% | 4 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $525 → $535 | $523.04 | +2.29% | 7 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $178.08 | - | 7 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $240.80 | n/a | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $14.02 | n/a | 16 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $175 | $264.17 | n/a | 9 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $37.41 | n/a | 25 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $4.53 | n/a | 1 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $58.30 | n/a | 9 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.80 | n/a | 14 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,050 | $0.0002 | n/a | 11 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $24.78 | n/a | 2 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $548.61 | n/a | 3 | Feb 2, 2021 |
HCA Healthcare
Jul 15, 2026
Reiterated: Hold
Price Target: n/a
Current: $373.75
Upside: -
Haemonetics
Jul 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $77.26
Upside: -
Integer Holdings
Feb 23, 2026
Reiterated: Buy
Price Target: $95 → $101
Current: $96.93
Upside: +4.20%
Guardant Health
Feb 23, 2026
Reiterated: Buy
Price Target: $61 → $129
Current: $150.64
Upside: -14.37%
Myriad Genetics
Jan 13, 2026
Maintained: Buy
Price Target: $8
Current: $5.71
Upside: +40.23%
Azenta
Nov 25, 2025
Reiterated: Buy
Price Target: $35 → $45
Current: $26.77
Upside: +68.10%
Avantor
Nov 4, 2025
Downgraded: Hold
Price Target: n/a
Current: $10.99
Upside: -
Revvity
Oct 28, 2025
Reiterated: Buy
Price Target: $115
Current: $110.51
Upside: +4.06%
QuidelOrtho
Aug 6, 2025
Maintained: Buy
Price Target: $60 → $55
Current: $16.41
Upside: +235.16%
Fulgent Genetics
Aug 4, 2025
Reiterated: Buy
Price Target: $25
Current: $19.54
Upside: +27.94%
Jul 24, 2025
Maintained: Buy
Price Target: $525 → $535
Current: $523.04
Upside: +2.29%
Jul 23, 2025
Reiterated: Hold
Price Target: n/a
Current: $178.08
Upside: -
Mar 28, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $240.80
Upside: n/a
Feb 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $14.02
Upside: n/a
Feb 10, 2025
Reiterated: Buy
Price Target: $85 → $175
Current: $264.17
Upside: n/a
May 13, 2024
Downgraded: Hold
Price Target: n/a
Current: $37.41
Upside: n/a
Jul 18, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $4.53
Upside: n/a
Feb 22, 2023
Reiterated: Hold
Price Target: n/a
Current: $58.30
Upside: n/a
Feb 15, 2023
Maintained: Hold
Price Target: n/a
Current: $3.80
Upside: n/a
Feb 24, 2022
Maintained: Buy
Price Target: $1,050
Current: $0.0002
Upside: n/a
Feb 11, 2021
Reiterated: Hold
Price Target: n/a
Current: $24.78
Upside: n/a
Feb 2, 2021
Reiterated: Hold
Price Target: n/a
Current: $548.61
Upside: n/a